Text Size

Home-based Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD) (COPD-HOME)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Community Health Network
Information provided by (Responsible Party):
St. Olavs Hospital
ClinicalTrials.gov Identifier:
NCT00702078
First received: June 19, 2008
Last updated: October 17, 2011
Last verified: October 2011
History of Changes

June 19, 2008
October 17, 2011
April 2008
December 2010   (final data collection date for primary outcome measure)
Number of hospitalizations [ Time Frame: 2011 ] [ Designated as safety issue: No ]
Number of hospitalizations ,quality of life [ Time Frame: 2011 ] [ Designated as safety issue: No ]
Complete list of historical versions of study NCT00702078 on ClinicalTrials.gov Archive Site
  • quality of life [ Time Frame: 2011 ] [ Designated as safety issue: No ]
  • lung function [ Time Frame: 2011 ] [ Designated as safety issue: No ]
  • use of medication [ Time Frame: 2011 ] [ Designated as safety issue: No ]
  • cost-effectiveness [ Time Frame: 2011 ] [ Designated as safety issue: No ]
lung function, use of medication, cost-effectiveness [ Time Frame: 2011 ] [ Designated as safety issue: No ]
Not Provided
Not Provided
 
Home-based Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD)
Randomised Clinical Study on the Effect of Homebased Treatment of Patients With COPD. Improved Cooperation Between Hospital and Primary Healthcare System.

We want to improve the treatment of patients suffering from COPD (3-4) by early medical intervention in the patients home. A close cooperation between the hospital and the primary healthcare system will hopefully reduce hospitalisation, drug consumption and improve quality of life. Following up from the hospital and the primary healthcare in cooperation may lead to earlier detection and treatment of exacerbations in COPD.

The main outcome variable will be number of hospitalizations assessed simply by counting. The second objective will be Quality of life and activation assessed by different questionnaires included in St.George´s Respiratory Questionnaire.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
COPD
  • Behavioral: closer collaboration between hospital and primary healthcare system
    Follow-up from the hospital and the primary healthcare in cooperation
  • Behavioral: usual care
    follow-up according to todays best practice
  • usual care
    follow-up according to todays best practice.
    Intervention: Behavioral: usual care
  • Experimental: cooperation
    Follow-up from the hospital and the primary healthcare in cooperation
    Intervention: Behavioral: closer collaboration between hospital and primary healthcare system
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
200
December 2013
December 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • clinical diagnosis of COPD (III-IV)
  • receive help from homecare nurse
  • not suffering from any other serious disease, with expected lifespan less than 6 months

Exclusion Criteria:

-
Both
up to 95 Years
No
Contact information is only displayed when the study is recruiting subjects
Norway
 
NCT00702078
17417
Yes
St. Olavs Hospital
St. Olavs Hospital
Community Health Network
Study Chair: Anne Hildur Henriksen, MD,PhD St.Olavs Hospital HF
St. Olavs Hospital
October 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP